Is there still a role for interferon-alpha for newly diagnosed chronic myeloid leukemia in chronic phase?
Quintás-Cardama
Alfonso
A
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Verstovsek
Srdan
S
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a